177 related articles for article (PubMed ID: 19615251)
21. Expression of E-selectin ligand-1 (CFR/ESL-1) on hepatic stellate cells: implications for leukocyte extravasation and liver metastasis.
Antoine M; Tag CG; Gressner AM; Hellerbrand C; Kiefer P
Oncol Rep; 2009 Feb; 21(2):357-62. PubMed ID: 19148508
[TBL] [Abstract][Full Text] [Related]
22. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
23. [Curcumine inhibits migration and invasion of hepatic stellate cells by reducing MMP-2 expression and activity].
Huang JX; Zhu BH; He D; Huang L; Hu K; Huang B
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):835-8. PubMed ID: 19958643
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
25. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
[TBL] [Abstract][Full Text] [Related]
26. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
Zheng S; Chen A
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G113-23. PubMed ID: 16959952
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
[TBL] [Abstract][Full Text] [Related]
28. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells.
Hellerbrand ; Wang SC; Tsukamoto H; Brenner DA; Rippe RA
Hepatology; 1996 Sep; 24(3):670-6. PubMed ID: 8781341
[TBL] [Abstract][Full Text] [Related]
29. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.
Jia YL; Shi L; Zhou JN; Fu CJ; Chen L; Yuan HF; Wang YF; Yan XL; Xu YC; Zeng Q; Yue W; Pei XT
Hepatology; 2011 Nov; 54(5):1808-18. PubMed ID: 22045676
[TBL] [Abstract][Full Text] [Related]
30. [A study on differentially expressed genes in hepatic stellate cells treated with transforming growth factor beta 1 using cDNA microarray technique].
Xiao L; Cheng J; Guo H; Hong Y; Zhang LY; Zhang YX; Zhang JL; Li Y
Zhonghua Gan Zang Bing Za Zhi; 2008 Oct; 16(10):752-6. PubMed ID: 18983772
[TBL] [Abstract][Full Text] [Related]
31. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation.
Chen C; Wu CQ; Zhang ZQ; Yao DK; Zhu L
Exp Cell Res; 2011 Jul; 317(12):1714-25. PubMed ID: 21586285
[TBL] [Abstract][Full Text] [Related]
32. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.
Ip WK; Lai PB; Wong NL; Sy SM; Beheshti B; Squire JA; Wong N
Cancer Lett; 2007 Jun; 250(2):284-91. PubMed ID: 17126992
[TBL] [Abstract][Full Text] [Related]
33. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
34. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P
Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
[TBL] [Abstract][Full Text] [Related]
36. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
[TBL] [Abstract][Full Text] [Related]
37. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells.
Ma J; Li F; Liu L; Cui D; Wu X; Jiang X; Jiang H
Liver Int; 2009 Apr; 29(4):567-74. PubMed ID: 19323783
[TBL] [Abstract][Full Text] [Related]
38. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
39. [Comparison between the suppression of tissue inhibitor of metalloproteinase-1 gene expression by recombinant adeno-associated virus carrying antisense RNA and small interfering RNA (siRNA) of TIMP-1 in rat hepatic stellate cells].
Cong M; Wang P; Liu TH; Xu Y; Lu Y; Tang SZ; Liu XM; Wang BE; Jia JD; You H
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):742-7. PubMed ID: 17064467
[TBL] [Abstract][Full Text] [Related]
40. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
